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Seizures in a term infant with Ohtahara syndrome, associated with polymicrogyria, nd a pre-term neonate 
with similar clinical features, failed to respond to conventional nticonvulsants, but were controlled with 
vigabatrin monotherapy. Another infant with Aicardi syndrome improved with vigabatrin. Autopsy in the 
first infant showed no evidence of intramyelinic oedema. The developmental outcome in the two survivors was 
better than expected for their condition. 
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INTRODUCTION 
Both Ohtahara syndrome (early infantile epi- 
leptic encephalopathy) and Aicardi syndrome 
have a dismal prognosis for seizure control and 
later neurodevelopmental progress. We de- 
scribe three neonates with these syndromes, 
one pre-term, whose fits responded to vigaba- 
trin. 
CASE REPORTS 
Case 1 
Multifocal clonic fits began on the first day of 
life and increased to a frequency of several, 
hourly. Pyridoxine, phenobarbitone, clonaze- 
pam and, later, sodium valproate, had no 
effect. By 20 days of age he was having hiccups, 
generalized myoclonic, generalized tonic-clo- 
nic, focal and tonic fits with desaturation, and 
needed ventilation. An EEG showed a burst 
suppression pattern. At 28 days vigabatrin. 
50 mg/kg/day, was started with immediate im- 
provement. His other anticonvulsants were 
stopped over the following week and he was 
extubated and discharged home on vigabatrin 
alone, 100 mg/kg/day, 1 week later. Myoclonic 
jerks recurred at 3 months and responded to an 
increased dose of vigabatrin. His EEG was 
unchanged. He remained hypertonic, with 
visual inattention and no developmental pro- 
gress and died from aspiration at 4 months. 
Chromosome analysis; blood ammonia, amino 
acids, biotinidase, very long chain fatty acids, 
dihydroxyacetone phosphate acyltransferase, 
and viral serology; urinary organic acids, oligo- 
saccharides and sulphite levels; CSF cell count, 
protein, amino acids and virology; cerebral 
ultrasound, CT and MRI scans; were normal. 
Neuropathological examination showed poly- 
microgyria. Electron microscopy of central 
white matter showed no evidence of intramye- 
linic oedema. 
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Case 2 
This boy was delivered at 26 weeks, weighing 
830g, following prolonged rupture of mem- 
branes, amnionitis and maternal chlamydial 
infection. He was electively ventilated from 
birth and given antibiotics. Abnormal move- 
ments occured on day 2, subtle seizures on day 
6, and tonic seizures with desaturation from 
day 8, when phenobarbitone was begun. Fre- 
quent desaturations with tonic upgaze, multi- 
focal and generalized myoclonic seizures fol- 
lowed and the EEG showed a severe burst 
suppression pattern. The addition of pyridox- 
ine, phenytoin, diazepam and clonazepam had 
no effect. A lignocaine infusion stopped the fits, 
which recurred when it was discontinued. 
Vigabatrin was then started, with immediate 
reduction in fit frequency, and the other drugs 
weaned over the next 3 days. His EEG re- 
mained abnormal, with asymmetry and imma- 
turity, but less-prolonged suppression periods. 
He was extubated and transferred back to his 
referring hospital. His fits recurred 2 weeks 
later but responded to an increased dose of 
vigabatrin, 100mg/kg/day. He has remained 
fit-free since, on vigabatrin 250 mg daily. He 
has an asymmetrical spastic quadriplegia nd 
developmental delay, but has started to use 
single words at a corrected age of 16 months. 
Blood and CSF aminoacids, urine organic acids 
and lumbar puncture were normal. Ultrasound 
scans showed mild bilateral ventricular dila- 
tation only. At 15 months, his EEG showed 
intermittent single anterior sharp waves but 
was otherwise normal, while'a CT scan demon- 
strated mild cortical atrophy. 
Case 3 
A girl presented on the second day of life with 
lei~-sided clonic jerks followed by a generalized 
tonic-clonic seizure, associated with hypocal- 
caemia (1.35 mmol/1; normal 2.2-2.7). Aicardi 
syndrome was diagnosed from absence of the 
corpus callosum on cerebral ultrasound and 
typical retinal lacunae on fundoscopy. EEG 
was normal. On day 28 myoclonic jerks began, 
associated with generalized EEG discharges, 
which were unresponsive to intravenous diaze- 
pam. These increased in frequency and became 
associated with recurrent desaturation. Viga- 
batrin 40mg/kg/day was given as first line 
treatment with cessation of clinical and EEG 
seizures and she was discharged. At 2 months 
the seizures recurred in association with an 
upper respiratory infection. Doubling the viga- 
batrin and the addition of carbamazepine 
stopped her fits. By 10 months she had only 
had three very brief partial seizures over the 
preceding 2 months. She has never had infan- 
tile spasms. 
DISCUSSION 
Vigabatrin had a useful therapeutic effect in 
these highly resistant seizures. Preventing 
episodic desaturation allowed the first two 
babies to be weaned from assisted ventilation. 
The mother of case 1 at first rejected him, but 
was able to cope with him at home once the fits 
stopped. 
Ohtahara syndrome consists of myoclonic, 
tonic (often with desaturation) and clonic seiz- 
ures, occurring soon after birth, in association 
with a suppression-burst EEG pattern. In 
many patients no cause is found, but recog- 
nized associations include birth asphyxia, 
neuronal migration defects and cerebral mal- 
formations, such as polymicrogyria. The fits 
are intractable and survivors develop infantile 
spasms, very severe mental retardation and 
cerebral palsy 1. Although Ohtahara syndrome 
has never been described in the pre-term, it 
remains the most probable diagnosis in our 
second case, who presented an identical clini- 
cal and EEG picture. Aicardi syndrome com- 
prises a characteristic association of intrac- 
table fits, usually infantile spasms, with 
retinal and cerebral malformations and occurs 
only in girls 2. 
Both these conditions are associated with 
virtually no developmental progress from the 
neonatal period. While the first infant made no 
progress until his death, the other two did 
better than expected. This may be coincidental, 
but could be due to good seizure control allow- 
ing some maturation of cerebral function. 
Vigabatrin is not licensed in the UK for use 
in neonates or for monotherapy of seizures. It 
has been used successfully in infants with 
infantile spasms, especially those with tuber- 
ose sclerosis 3. Intramyelinic oedema, an ill- 
understood effect of vigabatrin treatment in 
rats and dogs which has not been demonstrated 
in adult human autopsies 4, was not found in 
case 1, the first reported post-mortem study of 
an infant who had been given the drug. In neo- 
nates with this seizure and EEG association, 
the benefit of vigabatrin outweighs theoretical 
risks. 
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